Vascular endothelial growth factor A gene expression level is higher in patients with major depressive disorder and not affected by cigarette smoking, hyperlipidemia or treatment with statins

• Autorzy: Berent D. , Macander M. , Szemraj J. , Orzechowska A. , Galecki P.
• Języki publikacji: EN

Abstrakty

EN

Elevated levels of vascular endothelial growth factor (VEGF) are observed in conditions with vessel and neuron damage or pathological arborization and can therefore be detected in chronic inflammatory process, cardiovascular disease and depression. Hyperlipidemia and cigarette smoking are two factors that have been implicated in endothelial damage. The high comorbidity between cardiovascular disease and major depression disorder (MDD) prompted us to study the effect of cigarette smoking, hyperlipidemia and statin treatment on the VEGFA mRNA and protein expression levels measured in MDD patients. We analyzed 38 MDD patients and 38 healthy control individuals and observed that the MDD group had a significantly higher VEGFA mRNA level and protein serum concentration (P=0.001; P<0.001, respectively). We found no significant association between VEGFA expression at the mRNA or protein level and cigarette smoking, hyperlipidemia or treatment with statins (P>0.05). Interestingly, patients who had attempted suicide had a lower VEGF serum level compared with patients who had not attempted suicide. The translational value of this finding remains unknown. A higher VEGF concentration may play a potentially significant role in the pathogenesis of depression, and the expression level appears to be unaffected by additional factors.

• Wydawca: -
• Czasopismo: Acta Neurobiologiae Experimentalis
• Rocznik: 2014
• Tom: 74
• Numer: 1
• Opis fizyczny: p.82-90,ref.

Twórcy

autor

Berent D.

• Babinski Memorial Hospital, Lodz, Poland

autor

Macander M.

• Military Institute of Aviation Medicine, Warsaw, Poland

autor

Szemraj J.

• Department of Medical Biochemistry, Medical University of Lodz, Poland

autor

Orzechowska A.

• Department of Adult Psychiatry, Medical University of Lodz, Poland

autor

Galecki P.

• Department of Adult Psychiatry, Medical University of Lodz, Poland

Bibliografia

• APA - American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders. (4th ed). American Psychiatric Association, Washington DC.
• Anisman H (2011) Inflaming depression. J Psychiatry Neurosci 36: 291-295.
• Belgore FM, Lip GY, Blann AD (2000) Vascular endothelial growth factor and its receptor, Flt-1, in smokers and non- smokers. Br J Biomed Sci 57: 207-213.
• Bergeron M, Yu AY, Solway KE, Semenza GL, Sharp FR (1999) Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain. Eur J Neurosci 11: 4159-4170.
• Blann AD, Belgore FM, Constans J, Conri C, Lip GY (2001) Plasma vascular endothelial growth factor and its recep¬tor Flt-1 in patients with hyperlipidemia and atherosclero¬sis and the effects of fluvastatin or fenofibrate. Am J Cardiol 87: 1160-1163.
• Blumberg HP, Wang F, Chepenik LG, Kalmar JH, Edmiston E, Duman RS, Gelernter J (2008) Influence of vascular endothelial growth factor variation on human hippocam¬pus morphology. Biol Psychiatry 64: 901-903.
• Chancharoenthana W, Tiranathanagul K, Srisawat N, Susantitaphong P, Leelahavanichkul A, Praditpornsilpa K, Tungsanga K, Eiam-Ong S (2013) Enhanced vascular endothelial growth factor and inflammatory cytokine removal with online hemodiafiltration over high-flux hemodialysis in sepsis-related acute kidney injury patients. Ther Apher Dial 17: 557-563.
• Elderon L, Whooley MA (2013) Depression and cardiovas¬cular disease. Prog Cardiovasc Dis 55: 511-523.
• Feezor RJ, Baker HV, Mindrinos M, Hayden D, Tannahill CL, Brownstein BH, Fay A, MacMillan S, Laramie J, Xiao W, Moldawer LL,Cobb JP, Laudanski K, Miller-Graziano CL, Maier RV, Schoenfeld D, Davis RW, Tompkins RG and the Inflammation and Host Response to Injury, Large- Scale Collaborative Research Program (2004) Whole blood and leukocyte RNA isolation for gene expression analyses. Physiol Genomics 19: 247-254.
• Funatsu H, Yamashita H, Noma H, Mimura T, Yamashita T, Hori S (2002) Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema. Am J Ophthal 133: 70-77.
• Gacche RN, Meshram RJ (2013) Targeting tumor micro¬environment for design and development of novel anti- angiogenic agents arresting tumor growth. Prog Biophys Mol Biol 113: 333-354
• Giurgea AG, Margeta C, Maca T, Rezaie-Majd A, Bucek RA, Manavi M, Afarideh R, Minar E, Baghestanian M (2006) Simvastatin reduces serum level of vascular endothelial growth factor in hypercholesterolemic patients. J Cardiovasc Pharmacol 47: 30-36.
• Iga J, Ueno S, Yamauchi K, Numata S, Tayoshi-Shibuya S, Kinouchi S, Nakataki M, Song H, Hokoishi K, Tanabe H, Sano A, Ohmori T (2007) Gene expression and associa¬tion analysis of vascular endothelial growth factor in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 31: 658-663.
• Jin KL, Mao XO, Greenberg DA (2000) Vascular endothe- lial growth factor: Direct neuroprotective effect in in vitro ischemia. Proc Natl Acad Sci U S A 97: 10242-10247.
• Kahl KG, Bens S, Ziegler K, Rudolf S, Kordon A, Dibbelt L, Schweiger U (2009) Angiogenic factors in patients with current major depressive disorder comorbid with borderline personality disorder. Psychoneuro- endocrinology 34: 353-357.
• Kessler RC, Angermeyer M, Anthony JC, de Graaf R, Demyttenaere K, Gasquet I, de Girolamo G, Gluzman S, Gureje O, Haro JM, Kawakami N, Karam A, Levinson D, Mora MEM, Oakley Browne MA, Posada-Villa J, Stein DJ, Tsang CHA, Aguilar-Gaxiola S, Alonso J, Lee S, Heeringa S, Pennell BE, Berglund P, Gruber MJ, Petukhova M, Chatterji S, Üstün TB (2007) Lifetime prevalence and age-of-onset distributions of mental disor¬ders in the World Health Organization's World Mental Health Survey Initiative. World Psychiatry 6: 168-176.
• Lee BH, Kim YK (2012) Increased plasma VEGF levels in major depressive or manic episodes in patients with mood disorders. J Affect Disord 136: 181-184.
• Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408.
• Robins LN, Helzer JE, Croughan J, Ratcliff KS (1981) National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity. Arch Gen Psychiatry 38: 381-389.
• Schmidt-Lucke C, Belgore F, Reinhold D, Ansorge S, Klein HU, Schmidt-Lucke JA, Lip GYH (2005) Soluble vascu¬lar endothelial growth factor, soluble VEGF receptor Flt-1 and endothelial function in healthy smokers. International Journal of Cardiology 100: 207-212.
• Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A, Greenberg DA (2003) VEGF induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral isch¬emia. J Clin Invest 111: 1843-1851.
• Ventriglia M, Zanardini R, Pedrini L, Placentino A, Nielsen MG, Gennarelli M, Bocchio-Chiavetto L (2009) VEGF serum levels in depressed patients during SSRI antide¬pressant treatment. Prog Neuropsychopharmacol Biol Psychiatry 33: 146-149.
• Virgintino D, Errede M, D. Robertson, Girolamo F, Masciandaro A, Bertossi M (2003) VEGF expression is developmentally regulated during human brain angiogen- esis. Histochem Cell Biol 119: 227-232.
• Winer J, Jung CK, Shackel I, Williams PM (1999) Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for moni¬toring gene expression in cardiac myocytes in vitro. Anal Biochem 270: 41-49.
• Woollard KJ(2013) Immunological aspects of atherosclero¬sis. Clin Sci (Lond) 125: 221-235.
• Yamamoto T (2013) Angiogenic and inflammatory proper¬ties of psoriatic arthritis. ISRN Dermatol 2013: 630620.
• Zhang Y, Qiu H, Zhang H, Wang L, Zhuang C, Liu R (2013) Vascular endothelial growth factor A (VEGFA) polymor¬phisms in Chinese patients with rheumatoid arthritis. Scand J Rheumatol 42: 344-348.